glp 1 lawsuit update Ozempic – July 2026 class action lawsuit glp 1
Description
& Kozak, A
Pep is a GLP-1 tracker app designed to help people track medications like Ozempic, Wegovy, Zepbound, and Mounjaro
Run the formula
Empower recently attracted the attention of Eli Lilly, which sued Empower in April, saying it made false claims about its compounded tirzepatide, the active ingredient in Lillys Zepbound and Mounjaro drugs, being safe, effective and personalized, as well as the pharmacys adherence to state and federal regulations
Food and Drug Administration for use in 12- to 18-year-olds, Demi asked her mom if she thought it could work for her
